A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

Non-Hodgkin's lymphoma (NHL) occurs when lymphocytes called T cells and B cells become cancerous. Although there are many subtypes of lymphoma, skin lymphomas only make up about 4% of the total of all ...

The two main types are B lymphocytes (B cells) and T lymphocytes (T cells). B cells and T cells have different functions. Lymphomas are cancers of B and T cells. Cancers of the B cells act differently ...

Scientists used light to control how a starfish egg cell jiggles and moves during its earliest stage of development. Their optical system could guide the design of synthetic, light-activated cells ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

Wojciech Jurczak, MD, PhD, discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase inhibitors and degraders. Wojciech Jurczak, MD, PhD, head of the department of ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

Wojciech Jurczak, MD, PhD, discusses advancements in B-cell lymphoma therapy, focusing on immunotherapy, molecular-targeted agents, and more. Wojciech Jurczak, MD, PhD, head of the department of ...

Rituxan (rituximab) is not safe to receive while pregnant or breastfeeding. Certain factors, including the risk of fetal harm, may determine whether you should receive Rituxan treatment during ...

While HDAC inhibitors demonstrate efficacy against tumors such as T-cell lymphoma, they are also associated with significant side effects. Future research should aim to enhance subtype selectivity in ...